Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
This piece contrasts fee structures across popular index funds to help you pick the one with the lowest ongoing costs.
24,420 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Rhode Island housing reform advocates take stock after a truncated 2026 session ended without top-priority reform, se...
A new analysis shows Microsoft’s AI-driven revenue pace hitting fresh highs, suggesting meaningful upside for patient...
Investors are weighing a 32% drop in Netflix stock since April after Reed Hastings signaled a board exit. Here’s how ...
Wendy’s shares jumped about 27% on the CFO announcement, fueled by a Reddit-driven Save Wendy’s meme rally. Quarterly...
A sweeping shift is reshaping the auto industry. Here are two compelling reasons this massive global turnaround could...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
Apple shares fell sharply as memory costs tied to AI infrastructure pressured margins and prompted price bumps on sel...
XRP trades near $1 as traders await key support clusters that could define the next move. This report maps the crucia...
Veteran investor Jeremy Grantham warns that U.S. stock valuations have grown extremely stretched, signaling a potenti...
SoFi stock down more this year, yet chief executive Anthony Noto has been buying shares. This article breaks down wha...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...